The DVD Regimen After Myeloma Progression
Treatment of relapsed and refractory multiple myeloma | Haematologica
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management - Rajkumar - 2020 - American Journal of Hematology - Wiley Online Library
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Frontiers | Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis
Multiple myeloma current treatment algorithms | Blood Cancer Journal
ASCO 2016 Multiple Myeloma Update – Days One, Two, And Three
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
VAD and similar alternate regimens | Download Table
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study | BMJ Open
Multiple Myeloma - Oncologic Disorders - Pharmacotherapy A Pathophysiologic Approach, 9th Ed.
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
Approved for use in:
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study - ScienceDirect
Indications & Dosing | DARZALEX® (daratumumab) & DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) HCP
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Dosing & Treatment Plan for VELCADE® (bortezomib)
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion
